Diagnosis of GM-1 gangliodosis in Cuba
<strong>Background:</strong> GM-1 gangliosidosis is included in the group of lysosomal diseases and is characterized by a deficiency of the enzyme b-galactosidase, which as a consequence produces accumulation of GM1 ganglioside in nervous cells and galactosil oligosaccharides and product...
Main Authors: | Caridad Menéndez Saínz, Sergio González García, Claudina Zaldívar Muñoz, Alina González-Quevedo Monteagudo |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2007-05-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://www.medisur.sld.cu/index.php/medisur/article/view/257 |
Similar Items
-
Diagnosis of GM-1 gangliodosis in Cuba
by: Caridad Menéndez Saínz, et al.
Published: (2007-05-01) -
A propósito de un caso de gangliosidosis GM-2 tipo II: enfermedad de Sandhoff
by: Irelis González López, et al.
Published: (2015-06-01) -
Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
by: Sahil Mehta, et al.
Published: (2019-01-01) -
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
by: Rita Fischetto, et al.
Published: (2020-10-01) -
Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
by: Yuki Maeda, et al.
Published: (2016-02-01)